Overview

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin

Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
This study is being done to look at how tucatinib might affect the way another drug (metformin) works. It will look at healthy volunteers and how tucatinib affects how the body absorbs metformin. This will help us find out whether tucatinib is safe to give together with metformin. The study will also look at how tucatinib affects how the kidneys work.
Phase:
Phase 1
Details
Lead Sponsor:
Seagen Inc.
Seattle Genetics, Inc.
Treatments:
Metformin
Tucatinib